Therefore, inhibition of AChE is the most effective therapeutic approach to restore ACh concentrations in the brain and slows down Alzheimer’s disease (AD) symptoms [12,13]. This evidence concerns the gene ACHE and early-onset autosomal dominant Alzheimer disease.